ASCEND: Contract award for LF MDA and Morbidity Mapping

CROWN AGENTS LIMITEDcontractContracts FinderRef ZAMSA02SME suitableVCSE suitablecomplete
View buyer

Estimated value

£2.0m

Awarded value

£2.0m

Awarded 24 Jan 2020

Suppliers

1

Lots

1

1 awarded

Published

11 Jan 2021

Deadline 04 Dec 2019

Description

Accelerating the Sustainable Control and Elimination of NTDs (ASCEND) is an investment from the UK Government's Foreign, Commonwealth and Development Office (FCDO) to advance the impact and sustainability of national programme's tackling neglected tropical diseases (NTDs). ASCEND in South Asia, East and Southern Africa is implemented by a consortium of technical partners led by Crown Agents. Under the ASCEND programme, Crown Agents has awarded a subcontract to an Implementing Partner (IP) to provide Mass Drug Administration (MDA) and Morbidity Mapping for the treatment of Lymphatic Filariasis (LF), covering sixty-nine districts in nine of the ten regions of Zambia.

Scope

Reference
ZAMSA02
Total value
£1,975,104.88 excluding VAT
Commercial tool
Standalone contract
Contract dates
05 Mar 2020 to 14 Jun 2021
CPV classifications
73000000
Particular suitability
Small and medium-sized enterprises (SME)Voluntary, community and social enterprises (VCSE)

Submission & procedure

Submission deadline
04 Dec 2019, 11:00 pm

Award details

Awarded supplier(s), contract period and value as published in the award notice.

Awarded value

£2.0m

Award date

24 Jan 2020

Contract start

05 Mar 2020

Contract end

14 Jun 2021

Awarded to